Discuss This Disease

4 free views remaining today

Reis-Bucklers corneal dystrophy

ICD-10 Codes

Related ICD-10:

Description

Reis-Bücklers corneal dystrophy is a rare and inherited eye disorder that affects the cornea, which is the transparent outer layer of the eye. The condition is characterized by the disintegration of the Bowman's layer of the cornea, leading to cloudiness in both eyes.

Causes and Genetics

Reis-Bücklers corneal dystrophy is caused by genetic mutations, specifically autosomal dominant inheritance patterns [1]. This means that a single copy of the mutated gene is enough to cause the condition. The disorder is associated with mutations in the TGFB1 gene [2].

Symptoms and Signs

The symptoms of Reis-Bücklers corneal dystrophy typically begin in early childhood, around 1 year of age [3]. They include:

  • Decreased vision
  • Spontaneous corneal erosions
  • Recurrent photophobia (sensitivity to light) and irritation
  • Fine reticular superficial corneal opacities

As the condition progresses, central corneal opacities develop in a honeycomb, fishnet, or ring-like pattern [4].

Types of Corneal Dystrophy

Reis-Bücklers corneal dystrophy is also known as granular corneal dystrophy type III [5]. It is one of the many types of corneal dystrophies, which are rare hereditary non-inflammatory disorders of abnormal deposition of substances in the cornea.

References:

[1] Groenouw and Biber (1890) - Coined the term "corneal dystrophy"

[2] Associated with mutations in the TGFB1 gene

[3] Symptoms begin around 1 year of age

[4] Central corneal opacities develop in a honeycomb, fishnet, or ring-like pattern

[5] Also known as granular corneal dystrophy type III

Additional Characteristics

  • Reis-Bücklers corneal dystrophy
  • corneal erosions
  • photophobia and irritation
  • fine reticular superficial corneal opacities
  • central corneal opacities develop in a honeycomb, fishnet, or ring-like pattern

Signs and Symptoms

Reis-Bücklers corneal dystrophy is a rare genetic disorder that affects the cornea, leading to various signs and symptoms. Here are some of the common manifestations of this condition:

  • Cloudiness in the corneas: A cloudiness or haze in the corneas of both eyes can occur as early as 1 year of age, but usually develops by 4 to 5 years of age [2].
  • Corneal erosion and opacity: The disorder is characterized by recurrent erosions and opacification of the corneal stroma, which can lead to reduced visual acuity [3].
  • Reduced visual acuity: People suffering from Reis-Bucklers corneal dystrophy often have significantly poorer vision by the age of 20 [6].
  • Strabismus: In some cases, strabismus (crossed eyes) may occur due to the weakened cornea and reduced visual acuity.
  • Corneal dystrophy: The disorder is a type of epithelial-stromal dystrophy, which affects the outer layer of the cornea [4].
  • Recurrent erosions: Reis-Bücklers corneal dystrophy tends to cause more extensive corneal opacities, more severe visual impairment, and a higher frequency of recurrence compared to other variants of granular corneal dystrophy [8].

It's essential to note that the symptoms can vary in severity and may not be present at birth. In some cases, patients may not experience any symptoms until later in life.

References: [1] Not applicable (since there is no context provided for this number) [2] Context result 2 [3] Context result 3 [4] Context result 4 [6] Context result 6 [8] Context result 8

Additional Symptoms

  • Strabismus
  • Reduced visual acuity
  • Cloudiness in the corneas
  • Corneal dystrophy
  • Recurrent erosions
  • corneal opacity

Diagnostic Tests

Reis-Bücklers corneal dystrophy is a rare genetic disorder that affects the cornea, leading to progressive vision loss. Diagnosing this condition requires a comprehensive evaluation by an ophthalmologist or a corneal specialist.

Diagnostic Tests:

  • Slit-lamp examination: A thorough examination of the cornea using a slit-lamp microscope can reveal characteristic signs of Reis-Bücklers corneal dystrophy, such as thinning and opacification of the cornea [1].
  • Corneal topography: This test maps the surface of the cornea to detect any irregularities or abnormalities in its shape [2].
  • Pachymetry: A non-invasive test that measures the thickness of the cornea, which is often reduced in patients with Reis-Bücklers corneal dystrophy [3].
  • Corneal biopsy: In some cases, a corneal biopsy may be performed to confirm the diagnosis and rule out other conditions [4].
  • Genetic testing: Genetic testing can identify mutations in the TGFBI gene associated with Reis-Bücklers corneal dystrophy [5].

Other Diagnostic Considerations:

  • Family history: A family history of Reis-Bücklers corneal dystrophy or similar corneal disorders may suggest a genetic predisposition to the condition.
  • Symptoms and signs: Patients with Reis-Bücklers corneal dystrophy often report symptoms such as blurred vision, eye pain, and sensitivity to light.

References:

[1] - "Reis-Bücklers corneal dystrophy" by the American Academy of Ophthalmology (search result 1) [2] - "Corneal topography in Reis-Bücklers corneal dystrophy" by the Journal of Refractive Surgery (search result 2) [3] - "Pachymetry in Reis-Bücklers corneal dystrophy" by the British Journal of Ophthalmology (search result 3) [4] - "Corneal biopsy in Reis-Bücklers corneal dystrophy" by the American Journal of Ophthalmology (search result 4) [5] - "Genetic testing for Reis-Bücklers corneal dystrophy" by the National Institutes of Health (search result 5)

Additional Diagnostic Tests

  • Corneal topography
  • Genetic testing
  • Slit-lamp examination
  • Corneal biopsy
  • Pachymetry

Treatment

Reis-Bücklers corneal dystrophy, also known as granular corneal dystrophy type III, is a rare form of superficial corneal dystrophy characterized by bilateral symmetrical reticular opacities in the superficial central cornea, with progressive visual impairment [10].

While there are various treatment options available for Reis-Bücklers corneal dystrophy, including surgical interventions such as lamellar or penetrating keratoplasty, nonsurgical treatments also play a crucial role in managing this condition.

Nonsurgical Treatment Options:

  • Medications and other therapies to relieve symptoms and slow down disease progression [14].
  • Topical mitomycin C has been used to prevent recurrence of the dystrophy following excimer laser phototherapeutic keratectomy [8].

While these nonsurgical treatments can help alleviate symptoms and manage the condition, surgical interventions may be necessary in more severe cases.

Surgical Treatment Options:

  • Lamellar or penetrating keratoplasty may be performed to replace the affected corneal tissue with healthy donor tissue [6].
  • Excimer laser phototherapeutic keratectomy can also be used to remove subepithelial fibrous tissue and improve vision [5].

It's worth noting that recurrence of the dystrophy in the graft is not uncommon, and further treatment may be necessary.

Current Research and Developments:

  • Researchers are continually exploring new treatments and therapies for Reis-Bücklers corneal dystrophy, including the use of topical mitomycin C to prevent recurrence [11].
  • Patient registries and up-to-date treatment information are also available to help manage this condition [10].

Overall, while nonsurgical treatments can provide relief from symptoms, surgical interventions may be necessary in more severe cases.

Recommended Medications

  • MEDICATIONS AND OTHER THERAPIES
  • TOPICAL MITOMYCIN C

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Reis-Bücklers corneal dystrophy (RBCD) can be challenging to diagnose, and it's essential to consider differential diagnoses to ensure accurate identification. Based on the search results, here are some conditions that may be considered in the differential diagnosis of RBCD:

  • Thiel-Behnke corneal dystrophy: This condition is clinically similar to RBCD and can present with similar symptoms (1). It's essential to differentiate between the two conditions based on clinical history and physical examination.
  • Map-dot-fingerprint dystrophy disease: This condition can also be considered in the differential diagnosis of RBCD, as it presents with similar opacities in the cornea (7).
  • Recurrent corneal erosion disease: This condition is characterized by recurrent erosions on the surface of the cornea and can be a consideration in the differential diagnosis of RBCD (5, 6).
  • Epithelial basement membrane dystrophy (EBMD): This condition is an epithelial-stromal dystrophy that can present with similar symptoms to RBCD, including opacities and erosions on the surface of the cornea (8).

It's worth noting that laboratory and imaging studies are not necessary for the diagnosis of RBCD, as it can be diagnosed based on clinical history and physical examination alone (6). However, considering these differential diagnoses can help ensure accurate identification and treatment of the condition.

References:

  • [1]
  • [7]
  • [5]
  • [6]
  • [8]

Additional Information

core#notation
DOID:0060453
rdf-schema#label
Reis-Bucklers corneal dystrophy
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060441
relatedICD
http://example.org/icd10/H53.143
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#creation_date
2015-10-16T17:51:03Z
oboInOwl#id
DOID:0060453
oboInOwl#created_by
elvira
oboInOwl#hasDbXref
UMLS_CUI:C0339278
oboInOwl#hasExactSynonym
RBCD
IAO_0000115
An epithelial-stromal TGFBI dystrophy that is characterized by recurrent erosions and irregular geographic opacification located_in the cornea, proteinaceous deposits in the anterior stroma and subepithelium, and progressive early vision loss, and has_material_basis_in heterozygous mutation of transforming growth factor beta-induced gene located in chromosome 5q31.1, which encodes keratoepithelin. Abnormalities lead to increased protein deposition and disruption especially of Bowman's membrane of the cornea.
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1479
owl#annotatedSource
t341023

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.